Tag: life sciences
-
Engineered Immune, Stem Cells Studied for HIV Cure
Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections.
-
Partnership to Speed Covid-19 Clinical Trials
A company that aims to accelerate clinical trials is partnering with an entrepreneur and researcher to speed up the pace of new trials of Covid-19 vaccines, therapies, and diagnostics.
-
FDA Clears Video Game ADHD Therapy
A video game designed to help children improve their inattention and other symptoms of ADHD received authorization from the U.S. Food and Drug Administration.
-
Biotechs Partner on Crispr for Stem Cell Transplants
A biotechnology partnership is evaluating a synthetic antibody to make it safer for people with genetic diseases to receive gene-edited bone marrow stem-cell transplants.
-
Covid-19 Antibody Cocktail to Begin Clinical Trial
A combination of two synthetic antibodies, with an enhanced infection-blocking design for preventing and treating Covid-19 infections, is set to begin a clinical trial.
-
Crispr Heart Disease Start-Up Raises New $63M
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round.
-
Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-
Foundations Back ALS Biomarker Study
Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs.
-
Trial Indicates App Helps Treat Behavior Disorder
Results of a clinical trial suggest a smartphone app designed for use in a therapy program helps some people control their obsessive-compulsive disorder.
-
Covid-19 Vaccine for Lower-Income Regions Underway
Researchers in the U.K. designed a vaccine to prevent Covid-19 infections and is starting an enterprise to make it available to lower-income countries.